30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Vivo Capital Surplus Fund VIII, L.P.

Insider profile

Vivo Capital Surplus Fund VIII, L.P.'s trades of Terns Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-04-03 2024-04-03 PrS Proposed sale
24,590
411.42
US$3,941,361
24,590 411.42 US$3,941,361
2024-04-01 2024-04-01 PrS Proposed sale
53,343
346.56
US$1,078,693
53,343 346.56 US$1,078,693